65,437 trials
Irritable Bowel Syndrome Constipation Predominant
Primary: Colonic Transit, Colonic Geometric Center at 24 Hours — 2.39; 2.37; 2.02; 1.76 units on a scale
Hypertension · Angina Pectoris · Hypercholesterolemia
Primary: Number of Treatment Related Adverse Events. — 18 participants
Crohn's Disease
Primary: Number of Patients Reporting Side Effects — 2; 2; 0; 2 participants — p=1.0
Primary Hypercholesterolemia
Primary: Percentage Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at Week 12 — -27.70; -0.95 Percent Change — p=<0.001
Diabetic Foot Ulcers · Diabetic Foot Wounds
Primary: Change From Baseline in Extent of Presence/Absence of Epithelial Tongue. — NA; NA participants
Alcohol Dependence
Primary: Time to Relapse to Drinking — 69.9; 59.6; 57.3 days — p=0.04
Sepsis
Primary: Piperacillin Pharmacokinetics (PK) — 0.0799 L/hr/kg
Multiple Sclerosis
Primary: Number of Participants With Pre-specified Medical Events — 85; 75; 44; 14 Participants
Cataract
Primary: Demonstration That the Femtosecond Laser Consistently Produces Desired Incisions. — 2.75; 2.74 mm
Labor Induction · Cesarean Delivery
Primary: Cesarean Delivery — 32; 24 Cesarean deliveries
Body Contouring
Primary: Change in Combined Upper Arm Circumference Measurements From Baseline to Endpoint — 18; 1 participants
Diabetes Mellitus, Type 2
Primary: Change in HbA1c From Baseline to Week 26 — -0.03; -0.60; -0.73 Percent — p=<0.001
Herpes Zoster · Varicella-zoster Vaccine
Primary: Geometric Mean Titer (GMT) of the Antibody Responses to Varicella-Zoster Virus (VZV) — 248.0; 254.2; 389.1; 368.6 gpELISA Units/mL — p=<0.001
Attention Deficit Hyperactivity Disorder
Primary: Percentage of Participants Who Maintain a Satisfactory Response During the Double-Blind Maintenance/Randomized Withdrawal Period — 64.3; 50.0 percentage of responders…
Diabetes Mellitus, Type 2
Primary: Change in HbA1c From Baseline to Week 26 — -0.13; -0.85; -1.06 Percent — p=<0.001